Coherus Oncology, Inc. Common Stock
CHRS
CHRS
161 hedge funds and large institutions have $623M invested in Coherus Oncology, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
-13
Holders Change %
-7.47%
% of All Funds
2.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
60
Reduced
55
Closed
31
Calls
$1.18M
Puts
$1.26M
Net Calls
-$81K
Net Calls Change
+$594K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$53.7M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$10.4M |
| 3 |
3
BlackRock
New York
|
$112M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$46.1M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$51.5M |
